|
Some of you may have seen my post recently about what drug to take post-treatment for Her2 positive but ER/PR negative. I am almost thinking that I want to take Herceptin for a year after my radiation, but I have a lot more to read andthen to discuss with my oncologist.
I have another question....I am in need of some research advice. I need some data that discusses Her2 recurrance and type of cancer cell presented at recurrance. In other words, when Her2 positive patients have a recurrence, how often is the new cancer Her2+ and how often is it negative for Her2? And does it matter whether or not the patient is or has become post-menopausal after treatment--does that affect whether or not the recurrence overexpresses Her2? Has there been enough data collection of Her2 info to have statistics on this?
thanks!
Val Pfeiffer
|
Threaded Mode